CD276 and cancer: Overexpression of B7-H3 in tumor tissues is a poor prognostic biomarker in prostate cancer [29], upper tract urothelial carcinoma [30], small cell lung cancer [31], etc. Besides, inhibition of B7-H3 expression is a promising therapeutic strategy for human cancer.